
Diagnostics
Liquid Biopsy Screening for Gastric Cancer Is Not Cost-Effective at Current Prices
An economic simulation shows that blood-based gastric cancer screening is too expensive for average-risk individuals.
Emerging2 min read
Independent health-science reporting · Evidence ratedEvidence rated
Section
Advanced diagnostics move faster than the evidence that validates them. We cover liquid biopsy, multi-cancer detection, imaging, and pathology with attention to sensitivity, specificity, and real clinical consequence.

An economic simulation shows that blood-based gastric cancer screening is too expensive for average-risk individuals.

A retrospective study of a community-based program shows a significant drop in late-stage cases alongside signs of potential overdiagnosis.